The Real-World Evidence is Clear is a thought leadership podcast series from Thermo Fisher Scientific, the world leader in serving science, exploring the real-world questions shaping evidence generation, market access, health economics, and patient-centered research. Featuring expert conversations with internal specialists and external leaders from across industry, regulation and academia, the series examines timely issues with a technical, practical, and non-promotional lens. Designed for professionals working in clinical research, HEOR, market access, and related fields, the podcast focuses on rigorous discussion, credible insight, and the evolving role of data in supporting better healthcare decisions.

This episode explores the impact of AI on health technology assessment (HTA), focusing on whether AI makes work faster or better, and how to ensure credibility, transparency, and responsible use. Featuring Professor Gianluca Baio and Professor Rachael Hunter from University College London (UCL) and Matthew Bending and Jack Ishak from Thermo Fisher Scientific, the discussion covers validation, accreditation, industry roles, and future challenges in AI-enabled HTA.